Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.65 |
| ▸ | CES1 | P23141 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | SMO | Q99835 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | JAK2 | O60674 | 1/20 | 0.48 |
| ▸ | TYK2 | P29597 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.48 |
| ▸ | FEN1 | P39748 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17187884 | 1.00 | CES2 (0.65) | CES2CES1ALDH1A1POLBHPGD | |
| SCHEMBL29875158 | 1.00 | CES2 (0.65) | CES2CES1ALDH1A1POLBHPGD | |
| Methyl Alcohol SCHEMBL28944135 | 0.98 | CES2 (0.62) | CES2CES1ALDH1A1POLBHPGD | |
| Water SCHEMBL7070088 | 0.98 | CES2 (0.62) | CES2CES1ALDH1A1POLBHPGD | |
| Hydrochloric Acid SCHEMBL27995982 | 0.98 | CES2 (0.62) | CES2CES1ALDH1A1POLBHPGD | |
| Trimethylammonium SCHEMBL27857033 | 0.93 | CES2 (0.58) | CES2CES1ALDH1A1POLBHPGD | |
| SCHEMBL2153679 | 0.84 | CES2 (0.48) | CES2CES1ALDH1A1POLBHPGD | |
| Ethyl Acetate SCHEMBL28944126 | 0.83 | TSHR (0.52) | CES2CES1ALDH1A1POLBHPGD | |
| SCHEMBL1515824 | 0.82 | CES2 (0.50) | CES2CES1ALDH1A1POLBHPGD | |
| SCHEMBL699212 | 0.81 | TSHR (0.65) | CES2CES1ALDH1A1POLBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1615 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136801-A | Preparation method of (R) -1- (2-chlorophenyl) -2- (tetrazole-2-yl) ethyl carbamate | 浙江京新药业股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-115784987-B | Compound related to pneumonia as well as preparation method and application thereof and pharmaceutical composition | 国科温州研究院(温州生物材料与工程研究所) | 2025-05-27 | — | — | CN | claimed |
| CN-119191952-A | Ambacolat Process for the preparation of intermediates | 合肥立方制药股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118834123-A | Method for preparing alpha-bromo-o-chloroacetophenone by utilizing microchannel reactor | 江苏恩华药业股份有限公司 | 2024-10-25 | — | — | CN | claimed |
| CN-118184595-A | Method for preparing key intermediate of cinnolamine ester | 四川奥邦古得药业有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-115109759-B | Carbonyl reductase LsCR mutant, engineering bacterium and application thereof in preparation of chiral alcohol by asymmetric reduction of carbonyl compound | 浙江工业大学 | 2024-05-03 | — | — | CN | claimed |
| US-11958826-B1 | 6′-(2-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′- carbonitrile as an antimicrobial compound | King Faisal University (SA) | 2024-04-16 | — | — | US | claimed |
| WO-2024046712-A1 | METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE | Forschungszentrum Jülich GmbH (DE) | 2024-03-07 | — | — | WO | claimed |
| CN-117025581-A | Double-enzyme ordered immobilization method, product and application thereof | 杭州师范大学 | 2023-11-10 | — | — | CN | claimed |
| CN-116082133-A | Synthetic method of tulobuterol | 上海医药工业研究院 | 2023-05-09 | — | — | CN | claimed |
| EP-1854160-A2 | REDOX-ACTIVE STRUCTURES AND DEVICES UTILIZING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2007-11-14 | — | — | EP | claimed |
| WO-2006085319-A2 | REDOX-ACTIVE STRUCTURES AND DEVICES UTILIZING THE SAME | YEDA RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) | 2006-08-17 | — | — | WO | claimed |
| US-6833468-B2 | Reacting an optically active imine with a compound that is a hemiacetal of a perfluoroalkylaldehyde or a hydrate of a perfluoroalkylaldehyde to obtain a condensate, hydrolyzing | CENTRAL GLASS COMPANY, LIMITED (JP) | 2004-12-21 | — | — | US | claimed |
| EP-1080072-B1 | 2-(2-CHLOROPHENYL)-3,4-DIHYDRO-2H-PYRROL DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2004-08-04 | — | — | EP | claimed |
| EP-1349823-A1 | PROCESS FOR BASE-PROMOTED CONDENSATION REACTIONS AND BASE REAGENT THEREFOR | Crompton Corporation (US) | 2003-10-08 | — | — | EP | claimed |
| US-6489490-B1 | PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-12-03 | — | — | US | claimed |
| WO-2002055466-A1 | PROCESS FOR BASE-PROMOTED CONDENSATION REACTIONS AND BASE REAGENT THEREFOR | CROMPTON CORPORATION (US) | 2002-07-18 | — | — | WO | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-4417957-A | CHLORINATED ACETOPHENONES; ACRYLIC ACID AND/OR METHACRYLIC ACID | COLUMBIA CHEMICAL CORPORATION (US) | 1983-11-29 | — | — | US | claimed |
| US-4024193-A | Homogeneous hydrogenation process | ICI UNITED STATES INC. (US) | 1977-05-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11958826-B1 | 6′-(2-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′- carbonitrile as an antimicrobial compound | CLSPN, PNN, MFN2 | CES2 1159/4885CES1 4071/4885ALDH1A1 2689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.